Updates

Empresaria - Indian recruitment services side performing strongly

February 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Empresaria has said that including two months of trading from US healthcare recruiter Pharmaceutical Strategies, pretax profit will now come in ahead of expectations. Overall, 2015 was the second year of driving up conversion of NFI and it ended the year at 16%+, says chief executive Joost Kreulen, up from 12.4% at the H1 stage.Of course, upping the average has been Pharmaceutical Strategies where conversions are close to 40%. PS operates from a low cost office in Boston from which it covers the whole US, supplying temporary recruitment of pharmacy benefit managers (PBMs) who manage the buying and costing of drugs standing as a middle man between the insurers (with whom the medical plans are taken out) and patients and hospitals. U ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Wilmington

EMIS

Empresaria - Focus turns to organic growth (September 2019)

Empresaria - Forecast eps of 14.3p for this year (April 2017)

Empresaria - Buys niche IT contractor (November 2016)

Empresaria (September 2016)

Empresaria - Buys aviation recruiter (August 2016)

Empresaria - Buys high margin US healthcare recruiter (November 2015)

Empresaria - Will exceed market expectations (October 2015)

Empresaria - Forecast lifted to 8.8p for current year (April 2015)

Empresaria (February 2015)

Empresaria (January 2015)

Empresaria - Tiny acorn looks ready to grow (September 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X